Olanzapine plasma concentrations and clinical response in acutely ill schizophrenic patients.
作者： Paul J. Perry , Todd Sanger , Charles Beasley
DOI: 10.1097/00004714-199712000-00006
关键词: Therapeutic drug monitoring 、 Anesthesia 、 Plasma concentration 、 Schizophrenia 、 Olanzapine 、 Atypical antipsychotic 、 Psychology 、 Placebo 、 Internal medicine 、 Psychosis 、 Chemotherapy
摘要: Olanzapine is an atypical antipsychotic effective in the treatment of schizophrenic patients.After a 2- to 9-day placebo lead-in, 79 inpatients with schizophrenia according DSM-III-R criteria were placed on olanzapine dosage 10 mg/day or 1 for up 6 weeks. Blood samples obtain
lww.com 
sci-hub.st 参考文章(14)
Plasma clozapine levels and clinical response for treatment-refractory schizophrenic patients. American Journal of Psychiatry. ,vol. 152, pp. 179- 182 ,(1995) , 10.1176/AJP.152.2.179
Charles M Beasley Jr, Gary Tollefson, Pierre Tran, Winston Satterlee, Todd Sanger, Susan Hamilton, Olanzapine HGAD Study Group, Olanzapine versus placebo and haloperidol: Acute phase results of the North American double-blind olanzapine trial Neuropsychopharmacology. ,vol. 14, pp. 111- 123 ,(1996) , 10.1016/0893-133X(95)00069-P
ROC curves, test accuracy, and the description of diagnostic tests. Journal of Neuropsychiatry and Clinical Neurosciences. ,vol. 3, pp. 330- 333 ,(1991) , 10.1176/JNP.3.3.330
R J Cadoret, D D Miller, P J Perry, S V Arndt, Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients. American Journal of Psychiatry. ,vol. 148, pp. 231- 235 ,(1991) , 10.1176/AJP.148.2.231
Thomas R. E. Barnes, A rating scale for drug-induced akathisia. British Journal of Psychiatry. ,vol. 154, pp. 672- 676 ,(1989) , 10.1192/BJP.154.5.672
GUY CHOUINARD, BARRY JONES, GARY REMINGTON, DAVID BLOOM, DONALD ADDINGTON, G. WILLIAM MacEWAN, ALAIN LABELLE, LINDA BEAUCLAIR, WENDY ARNOTT, A Canadian Multicenter Placebo-Controlled Study of Fixed Doses of Risperidone and Haloperidol in the Treatment of Chronic Schizophrenic Patients Journal of Clinical Psychopharmacology. ,vol. 13, pp. 25???40- 40 ,(1993) , 10.1097/00004714-199302000-00004
Herbert Y. Meltzer, Duration of a Clozapine Trial in Neuroleptic-Resistant Schizophrenia Archives of General Psychiatry. ,vol. 46, pp. 672- 672 ,(1989) , 10.1001/ARCHPSYC.1989.01810070098017
MITSURU HASEGAWA, ROLANDO GUTIERREZ-ESTEINOU, LYNNE WAY, HERBERT Y. MELTZER, Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking Journal of Clinical Psychopharmacology. ,vol. 13, pp. 383- 390 ,(1993) , 10.1097/00004714-199312000-00003
C. M. Beasley, T. Sanger, W. Satterlee, G. Tollefson, P. Tran, S. Hamilton, Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial. Psychopharmacology. ,vol. 124, pp. 159- 167 ,(1996) , 10.1007/BF02245617
PAUL J. PERRY, DEL D. MILLER, STEPHAN ARNDT, REMI J. CADORET, Dr. Perry and Associates Reply American Journal of Psychiatry. ,vol. 148, ,(1991) , 10.1176/AJP.148.10.1406-B